- Six proteins predict kidney function decline in ADPKD.
- New model surpasses traditional clinical tools.
- Model explains 31.4% variance in eGFR decline.
- Validated in two independent patient cohorts.
- Proteins selected using wLASSO method.
- Model aids in treatment timing decisions.
- Further studies required to validate clinical application.
Source: nature communications